Candel Therapeutics Inc. (CADL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Candel Therapeutics Inc.

NASDAQ: CADL · Real-Time Price · USD
5.56
0.15 (2.77%)
At close: Oct 03, 2025, 3:59 PM
5.67
1.98%
After-hours: Oct 03, 2025, 06:19 PM EDT

Candel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
102.65M 35.41M 70.06M 82.64M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
266K n/a 266K 424K
Other Long-Term Assets
63K 382K 266K n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.15M 1.38M 1.89M 2.3M
Total Current Assets
103.8M 36.8M 71.94M 84.94M
Property-Plant & Equipment
2.73M 4.02M 5.48M 3.84M
Goodwill & Intangibles
n/a n/a -1.09M n/a
Total Long-Term Assets
3.06M 4.4M 5.75M 4.26M
Total Assets
106.87M 41.2M 77.69M 89.2M
Account Payables
237K 422K 380K 1.59M
Deferred Revenue
n/a n/a 144K n/a
Short-Term Debt
10.46M 8.89M 464K n/a
Other Current Liabilities
26.27M 2.34M 1.66M 1.68M
Total Current Liabilities
37.53M 14.18M 5.62M 5.36M
Long-Term Debt
2.6M 12.38M 20.85M 560K
Other Long-Term Liabilities
2.6M 916K 1.88M 19.15M
Total Long-Term Liabilities
3.01M 14.27M 24.36M 19.71M
Total Liabilities
40.54M 28.46M 29.98M 25.07M
Total Debt
13.47M 22.76M 22.8M 560K
Book Value
66.33M 12.74M 47.71M 64.14M
Book Value Per Share
2.09 0.44 1.66 2.24
Common Stock
469K 290K 290K 286K
Retained Earnings
-192.21M -137.03M -99.09M -80.3M
Comprehensive Income
n/a n/a -0.00 -89.2M
Shareholders Equity
66.33M 12.74M -99.09M 64.14M
Total Investments
266K 266K 266K 424K